ASTH (Astrana Health) Cyclically Adjusted Revenue per Share: $30.11 (As of Mar. 2026)


ASTH Astrana Health Inc ASTH
87 GF Score
Price $43.85
GF Value $82.34
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Cyclically Adjusted Revenue per Share?

Astrana Health ASTH -1.31% 87 Cyclically Adjusted Revenue per Share is $30.11 as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Astrana Health's adjusted revenue per share for the three months ended in Mar. 2026 was $19.674. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $30.11 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Astrana Health's average Cyclically Adjusted Revenue Growth Rate was 30.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 24.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 24.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 27.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Astrana Health was 40.80% per year. The lowest was 20.00% per year. And the median was 24.20% per year.

As of today (2026-06-29), Astrana Health's current stock price is $43.85. Astrana Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $30.11. Astrana Health's Cyclically Adjusted PS Ratio of today is 1.46.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Astrana Health was 10.87. The lowest was 0.67. And the median was 2.21.


Astrana Health  (NAS:ASTH) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Astrana Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=43.85/30.11
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Astrana Health was 10.87. The lowest was 0.67. And the median was 2.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Astrana Health Cyclically Adjusted Revenue per Share Related Terms


Astrana Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Astrana Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Cyclically Adjusted Revenue per Share Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.49 14.53 17.67 21.81 27.85

Astrana Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.13 24.39 26.22 27.85 30.11

ASTH vs SGRY, SEM, MD: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Astrana Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astrana Health Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Astrana Health's Cyclically Adjusted PS Ratio falls into.


ASTH
87GF Score
Astrana Health Inc ASTH
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Astrana Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=19.674/330.2130*330.2130
=19.674

Current CPI (Mar. 2026) = 330.2130.

Astrana Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2.062 241.018 2.825
201609 2.423 241.428 3.314
201612 2.598 241.432 3.553
201703 2.446 243.801 3.313
201706 6.890 244.955 9.288
201709 6.688 246.819 8.948
201712 0.000 246.524 0.000
201803 3.803 249.554 5.032
201806 3.745 251.989 4.908
201809 4.358 252.439 5.701
201812 2.803 251.233 3.684
201903 2.515 254.202 3.267
201906 3.426 256.143 4.417
201909 4.213 256.759 5.418
201912 5.140 256.974 6.605
202003 4.410 258.115 5.642
202006 4.430 257.797 5.674
202009 4.797 260.280 6.086
202012 -3.684 260.474 -4.670
202103 4.041 264.877 5.038
202106 3.832 271.696 4.657
202109 4.908 274.310 5.908
202112 4.279 278.802 5.068
202203 5.724 287.504 6.574
202206 5.860 296.311 6.530
202209 6.868 296.808 7.641
202212 6.466 296.797 7.194
202303 7.182 301.836 7.857
202306 7.444 305.109 8.056
202309 7.420 307.789 7.961
202312 7.491 306.746 8.064
202403 8.477 312.332 8.962
202406 10.135 314.175 10.652
202409 9.927 315.301 10.396
202412 13.854 315.605 14.495
202503 12.700 319.799 13.114
202506 13.236 322.561 13.550
202509 19.325 324.800 19.647
202512 19.185 324.054 19.550
202603 19.674 330.213 19.674

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $30.11 mean?
Astrana Health (ASTH) has a Cyclically Adjusted Revenue per Share of $30.11 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Astrana Health and its competitors.
Is Astrana Health's Cyclically Adjusted Revenue per Share too high?
Astrana Health's current Cyclically Adjusted Revenue per Share is $30.11. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Cyclically Adjusted Revenue per Share compare to SGRY and SEM?
Astrana Health's Cyclically Adjusted Revenue per Share of $30.11 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Astrana Health and its competitors. Astrana Health's current Cyclically Adjusted Revenue per Share is $30.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $43.85 — trading 46.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $30.11. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Astrana Health (ASTH), the current Cyclically Adjusted Revenue per Share is $30.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $43.85 is trading 46.7% below its estimated GF Value™ of $82.34. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Cyclically Adjusted Revenue per Share: $30.11
  • GF Value™: $82.34 vs. price of $43.85 (46.7% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.85
Price
$82.34
GF Value